Vagus Nerve Stimulation With EEG Feedback for Faster Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Vagus nerve stimulation (VNS) for treating chronic inflammation is challenging due to the slow manifestation of inflammation reduction, making it difficult to optimize stimulation settings, and there is a need for alternative markers or surrogates to indicate activation of the cholinergic anti-inflammatory pathway and identify suitable patients for therapy.

Innovation Solution

The method involves stimulating the vagus nerve, recording EEG to detect activation of the nucleus basalis and locus coeruleus, and adjusting stimulation parameters based on EEG feedback to enhance activation, including noninvasive stimulation of the auricular branch of the vagus nerve and using EEG to determine patient responsiveness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If vagus nerve stimulation is used to treat chronic inflammation, then anti-inflammatory effect is achieved, but it is difficult to optimize stimulation settings due to slow manifestation of inflammation reduction

Engineering Contradiction:
Improvetreatment efficacyVSAvoidtime to observe treatment effect
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent employs EEG feedback to monitor real-time activation of the nucleus basalis and locus coeruleus during vagus nerve stimulation. This immediate neural feedback allows clinicians to optimize stimulation parameters (frequency, amplitude, pulse width) based on actual brain activation patterns rather than waiting for delayed inflammatory markers, thereby resolving the contradiction between achieving reliable anti-inflammatory effects and the time required to observe them.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If traditional inflammation markers are used to monitor treatment progress, then treatment efficacy can be assessed, but optimization of stimulation parameters is delayed

Engineering Contradiction:
Improvetreatment monitoring accuracyVSAvoidtime delay in feedback
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent introduces EEG-measured neural activity in the nucleus basalis and locus coeruleus as an intermediary marker that reflects real-time activation of the cholinergic anti-inflammatory pathway. This intermediary provides immediate feedback about pathway activation, allowing for real-time optimization of stimulation parameters without waiting for traditional inflammatory markers (which take hours to days to change), thus resolving the time delay while maintaining measurement precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If high intensity vagus nerve stimulation is applied, then activation of the cholinergic anti-inflammatory pathway is enhanced, but patient comfort and safety may be compromised

Engineering Contradiction:
Improvepathway activation efficiencyVSAvoidpatient discomfort
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent implements dynamic adjustment of stimulation parameters based on real-time EEG feedback from the nucleus basalis and locus coeruleus. Rather than applying fixed high-intensity stimulation, the system continuously adapts pulse amplitude, frequency, and width to maintain optimal activation of the cholinergic pathway while staying within patient comfort thresholds. This dynamic approach maximizes pathway activation efficiency without causing excessive discomfort or safety issues.

Inventive Principle:
Principle #15Dynamics

4Ease of operation

If EEG monitoring is implemented to detect nucleus basalis and locus coeruleus activation, then real-time feedback for optimization is achieved, but device complexity increases

Engineering Contradiction:
Improveparameter optimization easeVSAvoidsystem complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent utilizes EEG technology, which is a well-established and widely available tool in clinical settings. By leveraging this existing universal technology for its specific purpose of monitoring nucleus basalis and locus coeruleus activation, the patent avoids the need to develop entirely new complex monitoring devices. The multi-functionality of EEG (already used for various neurological assessments) allows it to serve the specific function of tracking cholinergic pathway activation without significantly increasing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides immediate feedback for optimizing VNS parameters, enabling effective long-term potentiation of the inflammatory reflex and identifying responsive patients, thereby improving treatment efficacy.

Implementation Method 1

stimulating the vagus nerve... recording an EEG after the step of stimulating the vagus nerve

Methodology Applied
Scientific EffectElectrical stimulation: Electric Field

Implementation Method 2

recording an EEG after the step of stimulating the vagus nerve; determining from the recorded EEG whether at least one of the nucleus basalis and the locus coeruleus has been activated

Methodology Applied
Scientific EffectElectroencephalography (EEG): Electric Field

Data Source

PatentUS12383741B2Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
Publication Date: 2025.08.12 SETPOINT MEDICAL CORP
  • US12383741B2 patent drawing
  • US12383741B2 patent drawing
  • US12383741B2 patent drawing

AI summary

Described herein are methods and systems for using EEG recordings to improve vagus nerve stimulation (VNS) therapy. In particular, described herein are methods and systems for using EEG recordings to detect P300 and/or activation of the nucleus basalis and/or the locus coeruleus to determine the efficacy of VNS. The EEG recordings can be used to provide feedback control to help optimize stimulation parameters and to screen for patients that respond well to VNS therapy.